General Enquiries

For all general company inquires please send an email to: info.dk@xellia.com

Recruitment fraud alert

Xellia Pharmaceuticals has become aware of recruitment scams where fraudulent company representatives are contacting individuals and unauthorized appear to act on behalf of Xellia to offer fake job opportunities. Please note that Xellia’s use of recruitment companies to reach out to potential candidates never involves requests or authorises payment of any kind to process job applications or downloading of software.

If you have been contacted by anyone representing themselves as being from Xellia or on behalf of Xellia and are concerned about their legitimacy, please note that all actual open job positions at Xellia will be shown on our own website, here

If you have experienced any of these recruitment scams, please report to your local authorities. You can find more information on scams, as well as how to report a scam for the United States at https://www.consumer.ftc.gov/articles/0243-job-scams

  • Products
    • Active Pharmaceutical Ingredients (APIs)
    • Finished Dosage Forms (FDFs)
  • Expertise & capabilities
    • Quality
    • Supply chain
    • Environment, Health and Safety
  • Science & innovation
    • Innovation focus
    • Scientific culture
    • Scientific Advisory Board
    • Therapeutic focus
  • Partnering & Services
  • About us
    • Our company
    • Xellia at a glance
    • Ownership and leadership
    • Board of Directors
    • Our heritage
    • Our sites
    • Our values
    • Our purpose, goal and values
    • Our leadership promise
    • Corporate social responsibility
    • Code of Conduct
    • SOS Children's Villages
  • Careers
    • Careers at Xellia
    • Community at Xellia
    • Recruitment at Xellia
    • Job search
  • News and events
    • News and Press
    • Events and conferences
    • Corporate reports
  • Contact

You are about to be redirected to Xellia’s global website

We are now redirecting you to our global website, click ‘confirm’ below to continue or ‘cancel’ and we will return you to your previous page.

Cancel Confirm
  • About Xellia
  • Board of Directors
  • Ownership and management
  • Scientific Advisory Board
  • Products
  • Active Pharmaceutical Ingredients
  • Finished Dosage Forms
  • Science and innovation
  • Innovation focus
  • Therapeutic focus
  • Scientific culture

A company owned by Novo Holdings A/S

Main partner of SOS Children's Villages

© Xellia Pharmaceuticals 2021

  • Discover more
  • Social
  • Follow us on Linkedin
  • Cookie Policy testing
  • Privacy Policy
  • Terms of use